US 10676533
Methods of treatment of CD123 overexpressing disorders
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10676533 (Methods of treatment of CD123 overexpressing disorders) held by Aptevo Research and Development LLC expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aptevo Research and Development LLC
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P35/00